{
    "nct_id": "NCT05708352",
    "official_title": "A Randomized Controlled Phase 2 Study of the Ketogenic Diet Versus Standard Dietary Guidance for Patients With Newly Diagnosed Glioblastoma in Combination With Standard-of-care Treatment",
    "inclusion_criteria": "* Adults 18 years or older\n* Newly diagnosed glioblastoma (Within 2 months of initial diagnosis by histopathology)\n* Not started standard of care chemotherapy and/or radiation therapy for glioblastoma\n* Karnofsky Performance Status (KPS) â‰¥ 70\n* Ability to read, write and understand either English OR Spanish\n* Written informed consent obtained from subject and ability for subject to comply with the requirements of the study.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients with recurrent glioblastoma\n* Genetic disorders that affect lipid metabolism. Including but not limited to pyruvate carboxylase deficiency, porphyria, primary carnitine deficiency, carnitine palmitoyltransferase I or II deficiency, carnitine translocase deficiency, beta-oxidation defects\n* Inability to wean steroids below 8mg dexamethasone / day or equivalent\n* Body Mass Index (BMI) < 21kg/m2, unless the site Principal Investigator deems safe\n* Currently pregnant or nursing\n* Patients receiving other experimental therapy Note: Off-label therapy use is permitted\n* Comorbidities that in the opinion of the investigator limit the patient's ability to complete the study\n* Food preferences incompatible with keto diet\n* Using a pacemaker, implantable cardiac defibrillator, neurostimulator, cochlear implants (removable hearing aids permitted), or other electronic medical equipment, unless the site Principal Investigator deems safe\n* Inability to participant in standard of care MRIs",
    "miscellaneous_criteria": ""
}